Viveve Medical Q3 EPS $(13.51) Beats $(16) Estimate, Sales $1.052M Miss $3.43M Estimate

Viveve Medical (NASDAQ:VIVE) reported quarterly losses of $(13.51) per share which beat the analyst consensus estimate of $(16) by 15.56 percent. This is a 3364.1 percent decrease over losses of $(0.39) per share from

Benzinga · 11/07/2019 21:25

Viveve Medical (NASDAQ:VIVE) reported quarterly losses of $(13.51) per share which beat the analyst consensus estimate of $(16) by 15.56 percent. This is a 3364.1 percent decrease over losses of $(0.39) per share from the same period last year. The company reported quarterly sales of $1.052 million which missed the analyst consensus estimate of $3.43 million by 69.33 percent. This is a 78.18 percent decrease over sales of $4.821 million the same period last year.